PALESE, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 228
EU - Europa 223
AS - Asia 93
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 546
Nazione #
US - Stati Uniti d'America 225
IT - Italia 95
IN - India 59
IE - Irlanda 41
CN - Cina 28
SE - Svezia 27
DE - Germania 21
GB - Regno Unito 14
UA - Ucraina 11
CA - Canada 3
FI - Finlandia 3
TR - Turchia 3
BE - Belgio 2
PL - Polonia 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
EU - Europa 1
FR - Francia 1
MC - Monaco 1
MY - Malesia 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 546
Città #
Ann Arbor 45
Dublin 41
Chandler 40
Bangalore 27
Parma 23
Ashburn 18
Shanghai 10
Boardman 8
Wilmington 8
Fremont 7
Dearborn 6
Bremen 5
Faenza 5
Grafing 5
Princeton 5
Redwood City 5
Bologna 4
Falls Church 4
Guangzhou 4
Modena 4
Aulla 3
Florence 3
Helsinki 3
Ottawa 3
Redmond 3
Rho 3
Brussels 2
Caorso 2
Des Moines 2
Duncan 2
Houston 2
Kraków 2
Lonato 2
Milan 2
Montegaldella 2
New York 2
Norwalk 2
Pavia 2
Pesaro 2
Ponte Lambro 2
Reggio Emilia 2
Rimini 2
Shenyang 2
Ankara 1
Baotou 1
Borgonovo Val Tidone 1
Bratislava 1
Brno 1
Brooklyn 1
Casalgrande 1
Chicago 1
Esslingen am Neckar 1
Fairfield 1
Fidenza 1
Formigine 1
Frontone 1
Haikou 1
Istanbul 1
Kocaeli 1
Kuala Lumpur 1
London 1
Los Angeles 1
Lübeck 1
Monaco 1
Nanchang 1
Nanjing 1
Ningbo 1
Passirano 1
Pittsburgh 1
San Giuliano Milanese 1
Seattle 1
Segrate 1
Somerville 1
Taipei 1
Tulsa 1
Washington 1
Woodbridge 1
Zhengzhou 1
Zurich 1
Totale 362
Nome #
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 151
Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation 101
Multi-Target CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach 99
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 96
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 67
Discovery of small-molecule targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases 37
Su1816–Protection by Ccr6 Blockade in a Murine Model of Crohn’s Disease 16
Totale 567
Categoria #
all - tutte 1.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.711


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202071 0 3 0 0 0 18 20 3 4 10 8 5
2020/2021112 3 1 2 12 39 10 12 12 7 5 4 5
2021/2022147 12 4 13 49 24 9 7 6 5 6 2 10
2022/2023181 11 11 13 12 23 19 5 18 54 5 6 4
2023/202456 4 5 4 3 7 13 5 9 3 3 0 0
Totale 567